GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck KGaA (WBO:MRCK) » Definitions » Cyclically Adjusted PB Ratio

Merck KGaA (WBO:MRCK) Cyclically Adjusted PB Ratio : 3.27 (As of Apr. 30, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Merck KGaA Cyclically Adjusted PB Ratio?

As of today (2024-04-30), Merck KGaA's current share price is €149.75. Merck KGaA's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was €45.81. Merck KGaA's Cyclically Adjusted PB Ratio for today is 3.27.

The historical rank and industry rank for Merck KGaA's Cyclically Adjusted PB Ratio or its related term are showing as below:

WBO:MRCK' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 2.76   Med: 3.62   Max: 6.53
Current: 3.25

During the past years, Merck KGaA's highest Cyclically Adjusted PB Ratio was 6.53. The lowest was 2.76. And the median was 3.62.

WBO:MRCK's Cyclically Adjusted PB Ratio is ranked worse than
71.89% of 651 companies
in the Drug Manufacturers industry
Industry Median: 1.76 vs WBO:MRCK: 3.25

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Merck KGaA's adjusted book value per share data for the three months ended in Dec. 2023 was €61.365. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €45.81 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Merck KGaA Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Merck KGaA's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck KGaA Cyclically Adjusted PB Ratio Chart

Merck KGaA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.41 4.36 6.38 4.35 3.12

Merck KGaA Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.35 3.96 3.41 3.47 3.12

Competitive Comparison of Merck KGaA's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Merck KGaA's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merck KGaA's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merck KGaA's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Merck KGaA's Cyclically Adjusted PB Ratio falls into.



Merck KGaA Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Merck KGaA's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=149.75/45.81
=3.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Merck KGaA's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Merck KGaA's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=61.365/123.6675*123.6675
=61.365

Current CPI (Dec. 2023) = 123.6675.

Merck KGaA Quarterly Data

Book Value per Share CPI Adj_Book
201403 25.740 99.543 31.978
201406 25.669 99.543 31.890
201409 26.977 99.823 33.421
201412 27.006 99.543 33.551
201503 31.635 99.717 39.233
201506 31.825 100.417 39.194
201509 32.101 100.417 39.534
201512 29.410 99.717 36.474
201603 28.748 100.017 35.546
201606 29.410 100.717 36.112
201609 29.716 101.017 36.379
201612 32.175 101.217 39.312
201703 33.162 101.417 40.438
201706 31.524 102.117 38.177
201709 31.582 102.717 38.024
201712 32.207 102.617 38.814
201803 32.304 102.917 38.817
201806 34.119 104.017 40.565
201809 35.151 104.718 41.512
201812 39.560 104.217 46.943
201903 40.572 104.217 48.144
201906 40.365 105.718 47.219
201909 41.764 106.018 48.717
201912 41.035 105.818 47.957
202003 42.679 105.718 49.926
202006 41.359 106.618 47.973
202009 41.235 105.818 48.191
202012 38.976 105.518 45.680
202103 43.507 107.518 50.042
202106 44.374 108.486 50.584
202109 47.397 109.435 53.561
202112 49.078 110.384 54.984
202203 52.714 113.968 57.200
202206 59.697 115.760 63.775
202209 64.999 118.818 67.652
202212 59.633 119.345 61.793
202303 60.143 122.402 60.765
202306 61.413 123.140 61.676
202309 64.911 124.195 64.636
202312 61.365 123.668 61.365

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Merck KGaA  (WBO:MRCK) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Merck KGaA Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Merck KGaA's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Merck KGaA (WBO:MRCK) Business Description

Industry
Address
Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293
Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (47% of 2022 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (35%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (18%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

Merck KGaA (WBO:MRCK) Headlines

No Headlines